Cargando…
Status and Future Directions of Therapeutics and Prognosis of Cardiac Amyloidosis
Accumulation of aberrant proteins in the heart causes cardiac amyloidosis, an uncommon and complicated illness. It can be classified into two main types: light chain (AL) and transthyretin (ATTR). The diagnosis of cardiac amyloidosis is challenging due to its non-specific clinical presentation and l...
Autores principales: | Zhang, Wenbing, Ding, Jian, Wang, Wenhai, Wang, Duo, Pan, Yinping, Xu, Dexin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348342/ https://www.ncbi.nlm.nih.gov/pubmed/37457506 http://dx.doi.org/10.2147/TCRM.S414821 |
Ejemplares similares
-
Future Directions in Cardiac Amyloidosis
por: Trachtenberg, Barry
Publicado: (2022) -
Systemic AL amyloidosis: current approach and future direction
por: Bou Zerdan, Maroun, et al.
Publicado: (2023) -
Incidence, Diagnosis and Prognosis of Cardiac Amyloidosis
por: Lee, Min-Ho, et al.
Publicado: (2013) -
Cardiac Amyloidosis Determines the Prognosis of Systemic Amyloidosis; Roles and Responsibilities of Cardiologist
por: Lee, Ga Yeon, et al.
Publicado: (2013) -
Machine Learning Approaches in Diagnosis, Prognosis and Treatment Selection of Cardiac Amyloidosis
por: Allegra, Alessandro, et al.
Publicado: (2023)